And people don’t research medical drugs or medical procedures hardly anymore. A plethora of Industry-funding safety studies & buried studies on so many popular drugs that people would be stunned that some of this stuff actually gets approved by the FDA (who would have thought. Lol). And our trusted physicians? They are aware of the publication bias of the industry-funded studies published in the journals and most, IMO, simply don’t care. But I guess why would they if so many people demand the drugs anyway. And the drugs simply treat the symptoms making people more reluctant in making any dietary & lifestyle changes that might improve their condition.
Granted there are trauma situations from accidents & degenerative joint ailments that might necessitate medical drugs for the short term (I was hit & injured by a careless driver and required NSAIDs/pain meds for several musculoskeletal injuries). However, many other other chronic ailments (., hypertension, diabetes, acid reflux, obesity-related diseases, etc.) can be prevented with regular excercise, healthy organic food, dietary supplements, etc. But sadly many of the population are at all not interested (as we’ve become a very sedentary society with poor eating habits) and demand medical intervention & pharmaceuticals. And Big Pharma is all too willing to oblige laughing all the way to the bank. That’s why you’ll never see a poor Big Pharma sales rep.😉
The common procedure of invasive cardiac intervention and intravenous magnesium administration before reperfusion should without question become the gold standard in treatment of acute myocardial infarction.  Two meta-analyses studied the impact of magnesium treatment on reduction of the death rate and rhythm disorders in the acute phase of myocardial infarction before initiation of reperfusion treatments. Both reports found a 54% reduction of the death rate, and one noted a decreased incidence (49% less) of ventricular fibrillation or tachycardia in the population treated by magnesium.  The most important action of MgSO4 in AMI is to open up collateral circulation and relieve ischaemia thus reducing infarct size and mortality rates. 
November 17, September 20, July 13, May 18, April 11, February 27 and 7, 2017; November 9, August 26, July 7, June 30 and 9, May 31, 27, 24 and 9, April 29, March 30, February 25, January 25, 2016; December 28, November 5, October 1, September 16, August 6, July 22, June 1, May 18, April 3, March 9, February 25, January 14, 2015; January 27, 2012; December 21, November 14, October 13, September 22, August 24, June 17, April 13, March 3, January 25 and 6, 2011; December 15, October 29, September 16, August 30, July 7, 2010; December 18, October 29, September 21, August 26, June 30, May 14, April 1, 2009, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.